Antibiotic-Associated Delirium

Beta-Lactam Antibiotics and Delirium

Beta-lactam antibiotics, such as cefepime, cefazolin, and imipenem, can cause neurological toxicity including delirium through several mechanisms, with cefazolin having the highest pro-convulsive activity, making it most likely to cause neurological symptoms including delirium 1, 2
Cefepime has the second highest pro-convulsive activity, and imipenem has significant pro-convulsive activity, increasing the risk of delirium 1, 2
Piperacillin and ceftriaxone have lower but still significant neurotoxicity potential, contributing to the risk of delirium 2
Renal failure is the main risk factor for neurological toxicity due to beta-lactam accumulation, increasing the risk of delirium 1
High plasma concentrations of beta-lactams, such as cefepime, meropenem, and piperacillin, are associated with neurotoxicity and delirium 1

Avoid exceeding plasma free concentrations of beta-lactams above eight times the MIC to prevent neurotoxicity and delirium 1
Monitor renal function and adjust dosing accordingly in patients with renal impairment to prevent delirium 1

Asymptomatic bacteriuria with delirium should not be treated with antibiotics, as it has not been shown to improve mental status and may lead to adverse outcomes, including C. difficile infection 3, 4, 5
Infection is a frequent precipitating factor for delirium in cancer patients and should be treated if it aligns with the patient's goals of care, contributing to the management of delirium 6, 7, 8
Many antibiotics that cause delirium, particularly fluoroquinolones, can also prolong QT interval, increasing the risk of arrhythmias and contributing to the complexity of delirium management 9

If a patient has a true systemic infection requiring treatment, switching to a lower-risk antibiotic is preferable to complete cessation, as recommended by the European Society for Medical Oncology 10

Before administering sedating medications, address reversible factors, such as ensuring effective communication and reorientation, optimizing lighting in the room, exploring and addressing the patient's concerns and anxieties, and treating other reversible causes, as suggested by the British Medical Association 11
Educate caregivers on how they can help with reorientation, as recommended by the British Medical Association 11

Haloperidol is the first-line agent for delirium, with a starting dose of 0.5-1 mg orally at night and every 2 hours as needed, as recommended by the British Medical Association 11
For severely distressed patients or those causing immediate danger, consider a higher starting dose of 1.5-3 mg of haloperidol, as suggested by the British Medical Association 11
If agitation persists despite haloperidol, add a benzodiazepine, such as lorazepam or midazolam, as recommended by the British Medical Association 12
For agitation/restlessness without clear delirium, use benzodiazepines, such as lorazepam 0.5-1 mg orally four times daily as needed, as suggested by the British Medical Association 11

If the patient is on opioids, consider opioid toxicity as a contributor to delirium, especially with renal impairment causing metabolite accumulation, as recommended by the European Society for Medical Oncology 10
Opioid rotation with 30-50% dose reduction may alleviate delirium, as suggested by the European Society for Medical Oncology 10